Bevacizumab and death Patient Reports February 10, 2012

Bevacizumab Side Effects Report #6128366-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 18, 2009. Male patient, 61 years of age, weighting 138.7 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 5 MG/KG, DAYS 1+15/Q28D. During the same period patient was treated with DIPHENHYDRAMINE, ZOMETA. Patient died on 06/26/2008.

Bevacizumab Side Effects Report #6132534-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 19, 2009. Male patient, 61 years of age, weighting 138.7 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 5 MG/KG, DAYS 1+15/Q28D. During the same period patient was treated with DIPHENHYDRAMINE, ZOMETA. Patient died on 06/26/2008.

Bevacizumab Side Effects Report #5987857-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 24, 2008. Male patient was diagnosed with renal cell carcinoma, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with INTERFERON ALFA, CEFIXIME CHEWABLE, CEFOTAXIM, FLUCONAZOLE, PANTOPRAZOLE, CREMAFFIN, TRAMADOL, ACETAMINOPHEN. Patient died on 11/10/2008.

Bevacizumab Side Effects Report #5994570-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with TEMSIROLIMUS. Patient died on 08/08/2008.

Bevacizumab Side Effects Report #6019282-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 12, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 490 MG, Q2W. During the same period patient was treated with INTERFERON ALFA, LANSOPRAZOLE, ACETAMINOPHEN, OMEPRAZOLE. Patient died on 12/12/2008.

Bevacizumab Side Effects Report #6033642-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 29, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTRON A. Patient died.

Bevacizumab Side Effects Report #6034478-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 29, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALFA. Patient died.

Bevacizumab Side Effects Report #6035856-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 29, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTRON A, INTRON A, INTRON A. Patient died.

Bevacizumab Side Effects Report #5672527-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 05, 2008. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL, DECADRON, KYTRIL, VITAMIN A. Patient died on 02/24/2008.

Bevacizumab Side Effects Report #5700110-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 25, 2008. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL, DECADRON, KYTRIL, VITAMIN A. Patient died on 02/24/2008.

Bevacizumab Side Effects Report #5726497-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 18, 2008. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia

. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, OXYCONTIN, LASIX, DECADRON, ZOFRAN. Patient was hospitalized. Patient died on 01/29/2008.

Bevacizumab Side Effects Report #5620280-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 24, 2008. Male patient, 73 years of age, weighting 160.9 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, ONDANSETRON, DEXAMETHASONE, OMEPRAZOLE. Patient died on 01/10/2008.

Bevacizumab Side Effects Report #5632001-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 06, 2008. Male patient, weighting 160.9 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, ONDANSETRON, DEXAMETHASONE, OMEPRAZOLE. Patient died on 01/10/2008.

Bevacizumab Side Effects Report #5661743-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 27, 2008. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL. Patient died on 02/24/2008.

Bevacizumab Side Effects Report #5763345-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 24, 2008. Male patient, weighting 160.9 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, ONDANSETRON, DEXAMETHASONE, OMEPRAZOLE. Patient died on 01/10/2008.

Bevacizumab Side Effects Report #6025687-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2008. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma metastatic, dyspnoea and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Bevacizumab dosage: 835 MG, Q2W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, STEROIDS, OXYGEN. Patient was hospitalized. Patient died on 12/19/2008.

Bevacizumab Side Effects Report #5411493-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 07, 2007. Male patient, 52 years of age, weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/M2, DAYS 1+15/28DC. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATIVAN, CELEXA, LIDOCAINE MAALOX, DIPHENHYDRAMINE, REGLAN, SENNA. Patient died on 08/06/2007.

Bevacizumab Side Effects Report #5949168-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, dyspnoea. Bevacizumab dosage: 623 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LERCANIDIPINE. Patient was hospitalized. Patient died on 10/13/2008.

Bevacizumab Side Effects Report #6012458-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 03, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DOXORUBICIN. Patient died on 10/04/2008.

Bevacizumab Side Effects Report #5872691-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 22, 2008. Female patient was diagnosed with ovarian cancer, ovarian epithelial cancer and was treated with Bevacizumab. Bevacizumab dosage: 325 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient died.

Bevacizumab Side Effects Report #5359582-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 11, 2007. Male patient, weighting 204.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/M2, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient died on 06/01/2007.

Bevacizumab Side Effects Report #5375476-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 18, 2007. Male patient, weighting 204.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: malignant tumour excision. Bevacizumab dosage: 15 MG/M2, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient died on 06/10/2007.

Bevacizumab Side Effects Report #5441695-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 27, 2007. Male patient, weighting 204.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: oesophageal operation, unresponsive to stimuli. Bevacizumab dosage: 15 MG/M2, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN. Patient died on 06/10/2007.

Bevacizumab Side Effects Report #5452674-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Male patient, weighting 204.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: oesophageal carcinoma. Bevacizumab dosage: 15 MG/M2, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient died on 06/10/2007.

Bevacizumab Side Effects Report #6012666-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 27, 2006. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood lactate dehydrogenase increased, thrombocytopenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, METOPROLOL TARTRATE, LIPITOR, ASPIRIN, PROMOCARD, TAMSULOSINE, ZOLPIDEM. Patient died.

Bevacizumab Side Effects Report #5147189-7
Bevacizumab side effect was reported by a Health Professional from BRAZIL on Oct 19, 2006. Male patient, 74 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 7.5 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient died on 08/16/2006.

Bevacizumab Side Effects Report #6032123-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 02, 2009. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with VINORELBINE, CISPLATIN. Patient died.

Bevacizumab Side Effects Report #5662871-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 04, 2008. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1005 MG, Q3W. Patient died on 03/01/2008.

Bevacizumab Side Effects Report #5258247-0
Bevacizumab side effect was reported by a Health Professional from CANADA on Feb 16, 2007. Female patient, 63 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, PLATELETS, PRBC. Patient died on 12/01/2006.

Bevacizumab Side Effects Report #4848263-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 07, 2005. Female patient, 63 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 866 MG. During the same period patient was treated with ERLOTINIB. Patient died on 12/04/2005.

Bevacizumab Side Effects Report #5440810-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 22, 2007. Female patient, 56 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, LIPITOR, ATENOLOL, ACIPHEX, PREMARIN, ADVAIR DISKUS. Patient died.

Bevacizumab Side Effects Report #5301509-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, nausea

, pneumonia

, sepsis

. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.

Bevacizumab Side Effects Report #5323939-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 08, 2007. Female patient, weighting 161.0 lb, was diagnosed with non-small cell lung cancer, nausea

, anxiety

, constipation

, pulmonary embolism

, anxiety

, constipation

, pulmonary embolism

and was treated with Bevacizumab. Bevacizumab dosage: 1143 MG, Q3W. During the same period patient was treated with ELOXATIN, ALIMTA, ZOFRAN, XANAX, PHENERGAN, COLACE, COUMADIN, DILAUDID. Patient died on 02/13/2007.

Bevacizumab Side Effects Report #5354013-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 31, 2007. Male patient, weighting 83.74 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 689 MG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient died on 05/29/2007.

Bevacizumab Side Effects Report #5359004-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 07, 2007. Male patient, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1044 MG, Q3W. Patient died on 06/07/2007.

Bevacizumab Side Effects Report #5375416-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 20, 2007. Male patient, weighting 83.74 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 689 MG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN, FOLIC ACID, THIAMINE, PRILOSEC, MORPHINE SULPHATE SLOW RELEASE, MORPHINE SULPHATE SLOW RELEASE, KEPPRA. Patient died on 05/29/2007.

Bevacizumab Side Effects Report #5389202-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 04, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 850 MG, Q3W. During the same period patient was treated with ERLOTINIB, METFORMIN, ACETAMINOPHEN, CITALOPRAM HYDROBROMIDE. Patient died on 07/04/2007.

Bevacizumab Side Effects Report #5445536-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 22, 2007. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: unknown. During the same period patient was treated with NAVELBINE, CISPLATIN, ATARAX, PAROXETINE, NOCTRAN, SERETIDE, GAVISCON, DAFALGAN. Patient died.

Bevacizumab Side Effects Report #5463453-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 06, 2007. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 690 MG, Q3W. During the same period patient was treated with DICLOFENAC, OMEPRAZOLE. Patient died on 08/29/2007.

Bevacizumab Side Effects Report #5464755-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1110 MG, Q3W. Patient died on 09/09/2007.

Bevacizumab Side Effects Report #5481036-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 02, 2007. Female patient, weighting 102.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 735 MG, Q3W. During the same period patient was treated with ERLOTINIB. Patient died on 09/28/2007.

Bevacizumab Side Effects Report #5483728-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 27, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, HYDROMORPHONE, DILAUDID, DECADRON, PANTOPRAZOLE, METOCLOPRAMIDE, PROCHLORPERAZINE. Patient was hospitalized. Patient died on 08/24/2006.

Bevacizumab Side Effects Report #5491229-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 18, 2007. Female patient, weighting 102.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 735 MG, Q3W. During the same period patient was treated with ERLOTINIB. Patient died on 09/28/2007.

Bevacizumab Side Effects Report #5498366-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 15, 2007. Male patient, weighting 201.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ADVAIR DISKUS, ALBUTEROL, DUONEB, TYLOX, PROTONIX, MAXIPIME. Patient died on 09/22/2007.

Bevacizumab Side Effects Report #5510413-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 25, 2007. Female patient, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1071 MG, Q3W. During the same period patient was treated with DYTIDE, BLOPRESS, BELOC, TORSEMIDE, PANTOPRAZOLE, NOVOLOG, ACETYLCYSTEINE. Patient died on 10/05/2007.

Bevacizumab Side Effects Report #5526471-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 19, 2007. Male patient, weighting 142.0 lb, was diagnosed with non-small cell lung cancer, metastases to bone, hypomagnesaemia, anaemia, white blood cell count decreased and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN, ZOMETA, MAGNESIUM SULPHATE, PROCRIT, NEULASTA. Patient died on 10/24/2007.

Bevacizumab Side Effects Report #5536109-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 22, 2007. Male patient, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 885 MG, Q3W. During the same period patient was treated with ALLOPURINOL, ASPIRIN, ATROVENT, METOPROLOL, NOVODIGAL. Patient died on 11/13/2007.

Bevacizumab Side Effects Report #5611625-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 18, 2008. Female patient, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 892.5 MG, Q3W. During the same period patient was treated with VERGENTAN, OMEPRAZOLE, TORSEMIDE, EPOGEN, NEBIVOLOL, VIANI, SPIRIVA, DECORTIN. Patient died on 10/10/2007.

Bevacizumab Side Effects Report #5616153-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 29, 2008. Female patient, weighting 108.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB NOT ADMINISTERED. Patient died on 01/28/2008.

Bevacizumab Side Effects Report #5635264-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 08, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation

, intestinal perforation, pain

, peritonitis. Bevacizumab dosage: 690 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, DICLOFENAC, DOXEPIN, FENISTIL, GELOMYRTOLTE. Patient was hospitalized. Patient died on 08/29/2007.

Bevacizumab Side Effects Report #5641816-3
Bevacizumab side effect was reported by a Physician from GERMANY on Feb 14, 2008. Male patient, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1035 MG, Q3W. During the same period patient was treated with MOVICOL, FENTANYL, ACETYLCYSTEINE, OMEPRAZOLE, RAMIPRIL, VIANI, NOVAMINSULFON. Patient was hospitalized. Patient died on 01/22/2008.

Bevacizumab Side Effects Report #5651514-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, epistaxis, nausea

. Bevacizumab dosage: 1050 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CHLORPHENAMINE, CYCLIZINE, CODEINE SUL, ACETAMINOPHEN. Patient died.

Bevacizumab Side Effects Report #5653841-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 19, 2008. Male patient, weighting 152.1 lb, was diagnosed with non-small cell lung cancer, pulmonary embolism

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism

. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, HEPARIN. Patient died on 04/30/2007.

Bevacizumab Side Effects Report #5660673-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 25, 2008. Female patient, weighting 74.96 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. Patient died on 09/20/2007.

Bevacizumab Side Effects Report #5662799-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 05, 2008. Male patient, weighting 142.0 lb, was diagnosed with non-small cell lung cancer, metastases to bone, hypomagnesaemia, anaemia, white blood cell count decreased and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN, ZOMETA, MAGNESIUM SULPHATE, PROCRIT, NEULASTA. Patient died on 10/24/2007.

Bevacizumab Side Effects Report #5662864-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 27, 2008. Male patient, weighting 109.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient died on 02/16/2008.

Bevacizumab Side Effects Report #5680947-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 17, 2008. Male patient, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient died on 03/07/2008.

Bevacizumab Side Effects Report #5702902-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 27, 2008. Male patient was diagnosed with non-small cell lung cancer, septic shock, hypotension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: septic shock, stomatitis. Bevacizumab dosage: 1450 MG, Q3W. During the same period patient was treated with CISPLATIN, TAXOTERE, TICARCILLIN, CIPROFLOXACIN, LINEZOLID, NOREPINEPHRINE, POTASSIUM PHOSPHATE, TIENAM. Patient was hospitalized. Patient died on 08/29/2007.

Bevacizumab Side Effects Report #5708231-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoptysis. Bevacizumab dosage: 950 MG, Q3W. During the same period patient was treated with CARBOPLATIN, TAXOL, DUPHALAC, EFFERALGAN CODEINE, INNOHEP, KAYEXALATE, LEXOMIL. Patient died on 01/19/2008.

Bevacizumab Side Effects Report #5708338-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2008. Male patient, weighting 213.8 lb, was diagnosed with non-small cell lung cancer, septic shock, hypotension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: septic shock, stomatitis. Bevacizumab dosage: 1450 MG, Q3W. During the same period patient was treated with CISPLATIN, TAXOTERE, TICARCILLIN, CIPROFLOXACIN, LINEZOLID, NOREPINEPHRINE, POTASSIUM PHOSPHATE, TIENAM. Patient was hospitalized. Patient died on 08/29/2007.

Bevacizumab Side Effects Report #5746604-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2008. Male patient, weighting 133.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 865 MG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient died on 05/11/2008.

Bevacizumab Side Effects Report #5754529-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 16, 2008. Male patient, weighting 133.0 lb, was diagnosed with non-small cell lung cancer, pain

and was treated with Bevacizumab. Bevacizumab dosage: 865 MG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN, ZOFRAN, DEXAMETHASONE, ENDOCET, AVAPRO, ATIVAN. Patient died on 05/11/2008.

Bevacizumab Side Effects Report #5760186-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 21, 2008. Female patient, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1071 MG, Q3W. During the same period patient was treated with DYTIDE, CANDESARTAN CILEXETIL, BELOC, TORSEMIDE, PANTOPRAZOLE, NOVOLOG, ACETYLCYSTEINE. Patient died on 10/05/2007.

Bevacizumab Side Effects Report #5775893-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 02, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal adhesions, constipation

, intestinal perforation, pain

, peritonitis. Bevacizumab dosage: 690 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, DICLOFENAC, DOXEPIN, FENISTIL, FENTANYL, GELOMYRTOLTE. Patient was hospitalized. Patient died on 08/29/2007.

Bevacizumab Side Effects Report #5794236-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 13, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, constipation

, gastrointestinal perforation, peritonitis. Bevacizumab dosage: 690 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, DICLOFENAC, DOXEPIN, FENISTIL, FENTANYL, GELOMYRTOLTE. Patient was hospitalized. Patient died on 08/29/2007.

Bevacizumab Side Effects Report #5800690-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 18, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 150 MG/KG, Q21D. Patient died on 10/10/2007.

Bevacizumab Side Effects Report #5803508-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 23, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1275 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient died.

Bevacizumab Side Effects Report #5814129-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 04, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, constipation

, gastrointestinal perforation, peritonitis. Bevacizumab dosage: 690 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, DICLOFENAC, DOXEPIN, FENISTIL, FENTANYL CITRATE, GELOMYRTOLTE. Patient was hospitalized. Patient died on 08/29/2007.

Bevacizumab Side Effects Report #5815226-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 04, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1245 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, ANTIBIOTIC NOS. Patient died on 02/09/2008.

Bevacizumab Side Effects Report #5835950-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 23, 2008. Female patient, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 892.5 MG, Q3W. During the same period patient was treated with VERGENTAN, OMEPRAZOLE, TORSEMIDE, EPOGEN, NEBIVOLOL, VIANI, SPIRIVA, PREDNISONE. Patient died on 10/10/2007.

Bevacizumab Side Effects Report #5839080-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Male patient, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation

, intestinal perforation, sepsis

. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, ACIPHEX, SENOKOT. Patient died on 07/22/2008.

Bevacizumab Side Effects Report #5969118-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 13, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. Patient died on 08/26/2008.

Bevacizumab Side Effects Report #6009214-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 28, 2006. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, pericardial effusion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient died on 08/24/2006.

Bevacizumab Side Effects Report #6022138-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 16, 2008. Female patient, weighting 154.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 1071 MG, Q3W. During the same period patient was treated with DYTIDE, BLOPRESS, METOPROLOL TARTRATE, TORSEMIDE, PANTOPRAZOLE, NOVOMIX, ACETYLCYSTEINE. Patient died on 10/04/2007.

Bevacizumab Side Effects Report #6121278-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 03, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 780 MG, Q3W. Patient died on 04/15/2008.

Bevacizumab Side Effects Report #6121352-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2009. Male patient, weighting 179.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/M2, Q3W. During the same period patient was treated with ERLOTINIB. Patient died on 03/05/2009.

Bevacizumab Side Effects Report #4544460-4
Bevacizumab side effect was reported by a Consumer or non-health professional from on Jan 03, 2005. Male patient, weighting 132.3 lb, was diagnosed with neuroendocrine tumour and was treated with Bevacizumab. Bevacizumab dosage: 5 MG/KG D 1 + 15 INTRAVENOU. During the same period patient was treated with TEMOZOLOMIDE, ATIVAN, COMPAZINE, CREON, DOXAZOSIN, LASIX, LISINOPRIL. Patient died on 12/26/2004.

Bevacizumab Side Effects Report #5953957-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2008. Female patient, 57 years of age, weighting 138.9 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 7.5 MG/KG, Q21D. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, MORPHINE SULPHATE, ATIVAN. Patient died on 11/07/2008.

Bevacizumab Side Effects Report #6016568-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 16, 2008. Female patient, 57 years of age, weighting 138.9 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 7.5 MG/KG, Q21D. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, MORPHINE SULPHATE, ATIVAN. Patient died on 11/07/2008.

Bevacizumab Side Effects Report #6037711-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 06, 2009. Female patient, 57 years of age, weighting 138.9 lb, was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. Bevacizumab dosage: 7.5 MG/KG, Q21D. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, MORPHINE SULPHATE, ATIVAN. Patient died on 11/07/2008.

Bevacizumab Side Effects Report #5449224-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 06, 2007. Female patient, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN. Patient died on 09/03/2007.

Bevacizumab Side Effects Report #5471067-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 26, 2007. Female patient, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN. Patient died on 09/03/2007.

Bevacizumab Side Effects Report #5508349-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 22, 2007. Female patient, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, constipation

. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN. Patient was hospitalized. Patient died on 09/03/2007.

Bevacizumab Side Effects Report #5703494-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 02, 2008. Female patient was diagnosed with neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/M2, Q2W. During the same period patient was treated with FLUOROURACIL, HYDROXYUREA. Patient died.

Bevacizumab Side Effects Report #6014962-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 06, 2008. Male patient was diagnosed with lung neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W. Patient died on 01/14/2008.

Bevacizumab Side Effects Report #5915722-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 06, 2008. Male patient, 76 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB. Patient died on 10/01/2008.

Bevacizumab Side Effects Report #5941116-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2008. Male patient, 76 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, MEGACE, DURAGESIC, CARDIZEM, COUMADIN, HYDROCHLOROTHIAZIDE, LANOXIN, LOPRESSOR. Patient died on 10/01/2008.

Bevacizumab Side Effects Report #5303699-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 17, 2007. Male patient, 54 years of age, was diagnosed with hepatic neoplasm malignant, pain

and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, MARINOL, ATENOLOL, NEXIUM, SENOKOT, FENTANYL TRANSDERMAL SYSTEM, ACTIQ. Patient was hospitalized. Patient died on 03/26/2007.

Bevacizumab Side Effects Report #5800702-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 25, 2008. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB. Patient died on 06/19/2008.

Bevacizumab Side Effects Report #5807361-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 07, 2008. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB. Patient died on 06/19/2008.

Bevacizumab Side Effects Report #6009196-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 17, 2006. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: encephalopathy, sepsis

. Bevacizumab dosage: 355 MG, UNK. Patient was hospitalized. Patient died on 09/30/2006.

Bevacizumab and death

SideEffects101.com

Bevacizumab and death Patient Reports February 10, 2012

side effects of Bevacizumab